3 High Growth ASX Companies to Watch for Wealth Creation
Three ASX companies showing strong growth updates through new partnerships, financial results, user expansion and long term outlook, highlighting their ongoing business momentum.
Pro Medicus Limited (ASX: PME),
Pro Medicus Limited (ASX: PME),on 25 June 2026, announced a binding Heads of Agreement with Echo IQ for a finance facility and reseller arrangement to help develop and commercialise AI solutions for aortic stenosis and heart failure. The companies plan to complete final legal agreements within 20 business days.
The proposal includes an initial A$10 million investment, with an option for another A$10 million after FDA clearance of EchoSolv HF. The funding is intended to support Echo IQ’s US commercial activities.
The partnership also proposes Pro Medicus as a US reseller of the EchoSolv product suite, providing potential access to major health systems, academic medical centres and enterprise healthcare customers.
On 04 June 2026, Pro Medicus renewed its contract with The Ohio State University Wexner Medical Center for five years, valued at A$16 million, adding Visage 7 Workflow and Visage 7 Cardiology Imaging under a transaction-based pricing model.
Life360, Inc. (ASX:360),
Life360, Inc. (ASX:360), on 12 May 2026, shared record Q1 2026 figures. The total revenue was up 38% compared to a year ago at $143.1 million. The subscription revenue came in at $108.2 millionc and the annualized monthly revenue stood at $517.9 million. The advertising revenue rose to $19.7 million.
The monthly active users increased 17% to about 97.8 million. Paying Circles grew to 3.0 million after adding 201 thousand during the quarter. Average revenue per Paying Circle also increased during the period.
The company introduced new functionalities such as Temporary Location Sharing, Safety Incidents on the Map and Back on the Grid aimed at enhancing coordination and safety within the family unit. The firm had $459.0 million in cash, cash equivalents, restricted cash and short term investments at the end of the quarter.
The company upgraded its estimates for revenue and adjusted EBITDA but kept its estimates for ads and hardware the same for fiscal year 2026. 360 is expected to report its Q2 2026 earnings on 11 August 2026.
Light & Wonder, Inc. (ASX: LNW)
Light & Wonder, Inc. (ASX: LNW), on 13 May 2026, reported its first quarter 2026 results. There was a 2% increase in revenue compared to the prior year to $790 million. The company reported a 5% increase in consolidated AEBITDA to $327 million and an 86% increase in adjusted free cash flow to $207 million. Operating cash flow was $139 million.
Net income was $52 million, lower than last year because of about $50 million in legal reserve contingencies linked to legacy legal matters. Adjusted NPATA reached $115 million with adjusted earnings per share rising 7% to $1.45.
There was a 3% increase in gaming revenue to $512 million. There was a 38% increase in gaming operations and a 24% increase in table products revenue. Premium installed units in North America expanded for the 23rd straight quarter, Grover added 660 units, and the company shipped more than 5,000 gaming units.
On 13 May 2026, it expects mid to high single digit consolidated AEBITDA growth in 2026 and kept its 2028 targets unchanged.
(Source: Company Report)
Get Your Free Report on Top 5 ASX Stocks on WhatsApp
Instant Access. No Credit Card Required.
Receive on WhatsApp
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialASX Stock Research & Recommendations — 7‑day free trial
Independent, analyst‑driven insights.
- Stock of the week report
- Daily Analysis Report
- No credit card required
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Article
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
